Noriyuki Kawami Selected Research

Noriyuki Kawami Research Topics

18	Peptic Esophagitis (Reflux Esophagitis) 01/2024 - 05/2007
17	Non-Erosive Reflux Disease 01/2023 - 01/2009
11	Gastroesophageal Reflux (GERD) 01/2023 - 05/2007
4	Hemorrhage 01/2024 - 01/2017
3	Heartburn (Pyrosis) 01/2023 - 01/2021
3	Hiatal Hernia 01/2020 - 01/2017
2	Pathologic Constriction (Stenosis) 01/2024 - 01/2020
2	Esophageal Achalasia (Megaesophagus) 10/2023 - 07/2023
2	Hypersensitivity (Allergy) 01/2023 - 01/2021
2	Infections 01/2020 - 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Dyspepsia (Indigestion) 03/2022
1	Systemic Scleroderma (Systemic Sclerosis) 02/2022
1	Rumination Syndrome (Rumination Disorder) 01/2021
1	Constipation 01/2021
1	Eructation (Eructations) 01/2021
1	Carcinogenesis 10/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2020
1	Kyphosis 01/2020
1	Atrophy 01/2020
1	Hernia (Hernias) 01/2017
1	Esophagitis 01/2017
1	Eosinophilic Esophagitis 07/2015
1	Esophageal Motility Disorders (Nutcracker Esophagus) 07/2015
1	Pneumothorax 04/2015
1	Deglutition Disorders (Dysphagia) 12/2010
1	Pain (Aches) 05/2007

20	Proton Pump InhibitorsIBA 01/2024 - 05/2007
20	AcidsIBA 01/2023 - 05/2007
8	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2024 - 01/2017
4	PotassiumIBA 02/2022 - 01/2017
3	Epidermal Growth Factor (EGF)IBA 01/2023 - 01/2021
1	Z 338IBA 07/2023
1	Prednisolone (Predate)FDA LinkGeneric 04/2023
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	lemborexantIBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2022
1	liu-jun-zi-tangIBA 03/2022
1	LaxativesIBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	GastrinsIBA 10/2019
1	TabletsIBA 01/2019
1	A 19IBA 01/2017
1	Nizatidine (Axid)FDA LinkGeneric 01/2011
1	Histamine AgonistsIBA 01/2011
1	mosaprideIBA 04/2010
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2010
1	Phenobarbital (Luminal)FDA Link 01/2009